Results
1
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨128.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨395.24
7D
-0.2%
1Y
22.1%